(19)
(11) EP 2 632 933 A1

(12)

(43) Date of publication:
04.09.2013 Bulletin 2013/36

(21) Application number: 11740948.2

(22) Date of filing: 09.08.2011
(51) International Patent Classification (IPC): 
C07J 63/00(2006.01)
A61K 31/58(2006.01)
A61P 37/06(2006.01)
A61P 19/08(2006.01)
A61P 35/00(2006.01)
 A61K 31/56(2006.01)
A61P 29/00(2006.01)
A61P 17/00(2006.01)
A61P 31/00(2006.01)
A61P 3/00(2006.01)
(86) International application number:
PCT/EP2011/063702
(87) International publication number:
WO 2012/020021 (16.02.2012 Gazette 2012/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.08.2010 EP 10172411

(71) Applicant: onepharm Research & Development GmbH
1210 Wien (AT)

(72) Inventors:
  • CLASSEN-HOUBEN, Dirk
    1080 Vienna (AT)
  • KUEENBURG, Bernhard
    1190 Vienna (AT)
  • KOSMA, Paul
    1230 Vienna (AT)
  • JORDIS, Ulrich
    1180 Vienna (AT)
  • CZOLLNER, Laszlo
    2603 Felixdorf (AT)

(74) Representative: Gassner, Birgitta et al
REDL Life Science Patent Attorneys Donau-City-Straße 1
1220 Wien
1220 Wien (AT)

   


(54) GLYCYRRHETINIC ACID AMINE ANALOGUES FOR USE IN THE TREATMENT OF INFLAMMATION, INFECTIOUS DISEASES, CANCER, AUTOIMMUNE DISEASES, SKIN DISEASES, BONE DISEASES AND METABOLIC DISEASES